Searching for type 2 diabetes genes in the post-genome era

Trends in Endocrinology and Metabolism

Volumn 11, Issue 9, 2000, Pages 383-393

  Permutt, M Alan ^a   Hattersley, Andrew T ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b School of Postgraduate Medicine and Health Sciences   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOKINASE; HEPATIC NUCLEAR FACTOR 1ALPHA; HEPATIC NUCLEAR FACTOR 4ALPHA; HLA ANTIGEN; NUCLEAR FACTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; UNCLASSIFIED DRUG;

CHROMOSOME 12Q; CHROMOSOME 13Q; CHROMOSOME 17Q; CHROMOSOME 20Q; CHROMOSOME 7P; ETHNIC DIFFERENCE; GENE ISOLATION; GENETIC LINKAGE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR CLONING; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW;

ANIMAL; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; HUMAN; HUMAN GENOME PROJECT; PEDIGREE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0033775419     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(00)00329-5     Document Type: Review

References (87)

1. Genetics of diabetes mellitus
2. Genetics of NIDDM
3. Management of diabetes mellitus from a public health perspective
4. Searching for genetic determinants in the new millennium
5. Diabetes in America: Epidemiology and scope of the problem
6. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults - The third national health and nutrition examination survey, 1988-1994
7. Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance - A population-based twin study
8. Concordance rate for type II diabetes mellitus in monozygotic twins: Actuarial analysis
9. The epidemic of NIDDM in Asian and Pacific island populations - Prevalence and risk factors
10. Insulin resistance implications for type II diabetes mellitus and coronary heart disease
11. Epidemiology of non-insulin-dependent diabetes mellitus and its macrovascular complications - A basis for the development of cost-effective programs
12. Mapping genes in diabetes: Genetic epidemiological perspective
13. Glucokinase gene variants in the common form of NIDDM
14. PPAR-gamma: Adipogenic regulator and thiazolidinedione receptor
15. Dominant negative mutations in human PPAR-gamma associated with severe insulin resistance, diabetes mellitus and hypertension
16. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hppar gamma) gene in diabetic Caucasians: Identification of a Pro12Ala PPAR gamma 2 missense mutation
17. A pro12ala substitution in ppar-gamma-2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity
18. The Pro12Ala polymorphism in the peroxisome proliferator activated receptor gamma2 gene is associated with increased antilipolytic insulin sensitivity in lean, healthy subjects
19. The pro12ala variant of peroxisome proliferator-activated receptor-gamma2 (ppar-gamma2) is associated with measures of obesity in Mexican Americans
20. The pro 115gIn and pro12ala ppar gamma gene mutations in obesity and type 2 diabetes
21. Evaluation, using family-based association methods, of the role of the Pro12Ala variant in PPARG in pathogenesis of human insulin resistant phenotypes
22. The role of PPAR-gamma in insulin resistance and type 2
23. Association of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) Pro12Ala variant with type 2 diabetes-related phenotypes in a large Finnish cohort
24. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, irs-1, and irs-2
25. The glucokinase locus on chromosome 7p is closely linked to early onset non-insulin-dependent diabetes mellitus
26. A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome)
27. Wolfram syndrome: Evidence of a diffuse neurodegenerative disease by magnetic resonance imaging
28. Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome
29. Diabetes mellitus, diabetes insipidus, and optic atrophy: An autosomal recessive syndrome?
30. Linkage of the gene for Wolfram syndrome to markers on the short arm of chromosome 4
31. Reflexions on a newly discovered diabetogenic gene, wolframin (wfs1)
32. Maturity-onset diabetes of the young: Clinical heterogeneity explained by genetic heterogeneity
33. Maturity-onset diabetes of the young: A monogenic model of diabetes
34. A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria
35. Familial hypersinsulinism caused by an activating glucokinase mutation
36. Mutations in the glucokinase gene of the fetus result in reduced birth weight
37. Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene mody3 on chromosome 12
38. Defective pancreatic beta-cell glycolytic signaling in hepatocyte nuclear factor-1alpha-deficient mice
39. Genetic testing in maturity onset diabetes of the young (MODY): A new challenge for the diabetic clinic
40. Mutations in the hepatocyte nuclear factor 4a gene in maturity onset diabetes of the young (MODY1)
41. Mutation in the hnf-4 alpha gene affects insulin secretion and triglyceride metabolism
42. Transcribing pancreas
43. Beta-cell-specific inactivation of the mouse ipf1/pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes
44. Pancreatic agenesis attributable to a single nucleotide deletion in the human ipf1 gene coding sequence
45. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1
46. Missense mutations in the insulin promoter factor 1 (IPF-1) gene predispose to type 2 diabetes
47. Abnormal nephron development associated with a frameshift mutation in the transcription factor hepatocyte nuclear factor-1 beta
48. A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-pou domain of hepatocyte nuclear factor-1beta
49. No evidence for linkage at candidate type 2 diabetes susceptibility loci on chromosomes 12 and 20 in United Kingdom Caucasians
50. Mitochondrial diabetes mellitus: A review
51. Mutation in mitochondrial trna(leu)(uur) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness
52. A mutation in the trna(leu,uur) gene associated with the melas subgroup of mitochondrial encephalomyopathies
53. Maternally inherited diabetes and deafness: A new diabetes subtype
54. A genome-wide search for human non-insulin dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2q
55. Genetic variation in the calpain 10 gene affects susceptibility to type 2 diabetes in Mexican Americans
56. Genomewide search for type 2 diabetes susceptibility genes in four American populations
57. Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans
58. Evidence for linkage of regions on chromosomes 6 and 11 to plasma glucose concentrations in Mexican Americans
59. An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians
60. Linkage of chromosomal markers on 4q with a putative gene determining maximal insulin action in Pima Indians
61. Evidence for linkage between a region on chromosome 1p and the acute insulin response in Pima Indians
62. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes
63. An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians
64. A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians
65. Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families
66. Type 2 diabetes: Evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs
67. A susceptibility locus for early-onset non-insulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene
68. Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy
69. New susceptibility locus for NIDDM is localized to human chromosome 20q
70. Molecular characterization of the human pea 15 gene on 1q21-q22 and association with type 2 diabetes mellitus in Pima Indians
71. Pharmacogenetics and the practice of medicine
72. High-resolution genetic mapping of complex traits
73. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results
74. Recent progress in psychiatric genetics - Some hope but no hype
75. A large sample of Finnish diabetic sib-pairs reveals no evidence for a non-insulin-dependent diabetes mellitus susceptibility locus at 2qter
76. Single nucleotide polymorphism libraries: Why and how are we building them?
77. Linkage disequilibrium as a genetic-mapping tool
78. Mapping genes through the use of linkage disequilibrium generated by genetic drift - Drift mapping in small populations with no demographic expansion
79. Prospects for whole-genome linkage disequilibrium mapping of common disease genes
80. The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases i. DNA pooling
81. The genetically isolated populations of Finland and Sardinia may not be a panacea for linkage disequilibrium mapping of common disease genes
82. Juxtaposed regions of extensive and minimal linkage disequilibrium in human Xq25 and Xq28
83. The transmission/disequilibrium test detects cosegregation and linkage
84. Evidence for linkage of post challenge insulin levels with intestinal fatty acid-binding protein (fabp2) in Mexican-Americans
85. Linkage analysis of 19 candidate regions for insulin resistance in familial NIDDM
86. Evidence of a novel type 2 diabetes locus 50 cm centromeric to NIDDM2 on chromosome 12q
87. Genetic studies of the sulfonylurea receptor gene locus in NIDDM and in morbid obesity among French Caucasians